GlassScriptPhysician profile
Shiva Satish
NPI 1629099635
$577.23
in general payments reported to CMS, 2019-2025
17 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.58 · 2020: $158 · 2021: $12.12 · 2022: $127 · 2023: $83.76 · 2024: $73.31 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $126.93 | 2022 | |
| Boston Scientific Corporation | $123.24 | 2020 | |
| Phathom Pharmaceuticals, INC. | $35.15 | 2024 | Voquezna |
| Allergan, INC. | $34.31 | 2020 | |
| Sanofi-Aventis U.S. LLC | $29.84 | 2023 | |
| Amgen INC. | $28.29 | 2025 | Otezla, Repatha |
| Lilly USA, LLC | $23.79 | 2025 | Mounjaro |
| Pfizer INC. | $22.45 | 2025 | |
| Astellas Pharma US INC | $22.14 | 2023 | Veozah |
| Medtronic, INC. | $21.12 | 2025 | Inceptiv |
| Novo Nordisk INC | $20.00 | 2024 | Ozempic, Rybelsus |
| Azurity Pharmaceuticals, INC. | $18.16 | 2024 | Horizant |
| Dexcom, INC. | $17.01 | 2023 | Dexcom G6 Transmitter |
| Vifor Pharma, INC. | $14.77 | 2023 | Veltassa |
| Currax Pharmaceuticals LLC | $14.33 | 2025 | Contrave |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $13.58 | 2019 | |
| Avanir Pharmaceuticals, INC. | $12.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shiva Satish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.